Trial Profile
A randomized, double blind, placebo controlled study investigating the effect of Dapagliozin treatment on blood pressure and visceral adiposity in subjects with obesity or overweight without diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2016
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 21 Sep 2016 New trial record